Reconstruction of Skin Substance Loss With "Micro-grafts" Obtained by Mechanical Disintegration
MG-1
1 other identifier
observational
70
1 country
4
Brief Summary
The etiology of non-healing ulcers depends on both systemic and local factors. The introduction of advanced dressing, negative wound therapy and compression therapy have undoubtedly improved clinical outcomes. The principal aim of study was to demonstrate the efficacy of skin micrografts in the treatment of skin substance loss.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2017
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedFirst Submitted
Initial submission to the registry
July 17, 2019
CompletedFirst Posted
Study publicly available on registry
July 24, 2019
CompletedJuly 24, 2019
July 1, 2019
1 year
July 17, 2019
July 23, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Wound Bed Score values
Percentage of patients with change of the Wound Bed Score values higher than 50%, after 30 days,
change of baseline wound bed score values at day 30
Secondary Outcomes (2)
Spontaneous re-epithelialization.
Day 0 and Day 30
Vancouver scale
Day 30, Day 90 and Day 180
Eligibility Criteria
Patients who attend the various regional hospitals through the emergency room or surgical clinic
You may qualify if:
- Full-thickness skin loss from a minimum size of 3x3 cm (9cm2) to a maximum size of 5x5 cm (25cm2);
- Loss of substance caused by abrasive-contusive traumas (loss of full-thickness skin substance) or by thermal burn (deep degree II), present for at least 15 days;
- Absence of clinical signs of infection assessed by two culture swabs performed at T0 (pre and post debridement);
- Pre-operative inflammatory index (VES, PCR) and b-hcg negative;
- Absence of exposure of osteo-cartilaginous structures, of noble structures (major arterial vessels, major nerve trunks, tendons without paratenon);
- Specific written informed consent
You may not qualify if:
- Smoking patients (≥ 10 cigarettes / day);
- Patients with type I or type II diabetes mellitus:
- Patients suffering vascular trophic ulcers;
- Patients with loss of substance at the level of the fingers and toes;
- Patients with loss of substance of the foot and the yarrow region;
- Patients with oncological pathologies in progress or in remission;
- Patients in therapy with immunosuppressive and corticosteroid drugs, anticoagulants, antiplatelet agents;
- Patients with autoimmune diseases including connectivitis;
- Patients with congenital, acquired and metabolic immunodeficiencies;
- Pregnant patients (ascertained with β-HCG) and breastfeeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Azienda Ospedaliera Universitaria Ospedali Riuniti
Ancona, AN, 60126, Italy
IRCCS Policlinico San Donato
Milan, MI, Italy
Università degli Studi di Udine
Udine, UD, Italy
Università degli Studi di Roma "La Sapienza"
Roma, Italy
Related Publications (10)
Greaves NS, Ashcroft KJ, Baguneid M, Bayat A. Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing. J Dermatol Sci. 2013 Dec;72(3):206-17. doi: 10.1016/j.jdermsci.2013.07.008. Epub 2013 Jul 30.
PMID: 23958517RESULTTrovato L, Monti M, Del Fante C, Cervio M, Lampinen M, Ambrosio L, Redi CA, Perotti C, Kankuri E, Ambrosio G, Rodriguez Y Baena R, Pirozzi G, Graziano A. A New Medical Device Rigeneracons Allows to Obtain Viable Micro-Grafts From Mechanical Disaggregation of Human Tissues. J Cell Physiol. 2015 Oct;230(10):2299-303. doi: 10.1002/jcp.24973.
PMID: 25728337RESULTMarcarelli M, Trovato L, Novarese E, Riccio M, Graziano A. Rigenera protocol in the treatment of surgical wound dehiscence. Int Wound J. 2017 Feb;14(1):277-281. doi: 10.1111/iwj.12601. Epub 2016 Apr 29.
PMID: 27126653RESULTBaglioni E, Trovato L, Marcarelli M, Frenello A, Bocchiotti MA. Treatment of Oncological Post-surgical Wound Dehiscence with Autologous Skin Micrografts. Anticancer Res. 2016 Mar;36(3):975-9.
PMID: 26976986RESULTSvolacchia F, De Francesco F, Trovato L, Graziano A, Ferraro GA. An innovative regenerative treatment of scars with dermal micrografts. J Cosmet Dermatol. 2016 Sep;15(3):245-53. doi: 10.1111/jocd.12212. Epub 2016 Jan 30.
PMID: 26825041RESULTDe Francesco F, Graziano A, Trovato L, Ceccarelli G, Romano M, Marcarelli M, Cusella De Angelis GM, Cillo U, Riccio M, Ferraro GA. A Regenerative Approach with Dermal Micrografts in the Treatment of Chronic Ulcers. Stem Cell Rev Rep. 2017 Feb;13(1):139-148. doi: 10.1007/s12015-016-9692-2.
PMID: 27738884RESULTFalanga V, Saap LJ, Ozonoff A. Wound bed score and its correlation with healing of chronic wounds. Dermatol Ther. 2006 Nov-Dec;19(6):383-90. doi: 10.1111/j.1529-8019.2006.00096.x.
PMID: 17199681RESULTQi X, Ding L, Huang W, Wen B, Guo X, Zhang J. An improved automated type-based method for area assessment of wound surface. Wound Repair Regen. 2017 Jan;25(1):150-158. doi: 10.1111/wrr.12495. Epub 2017 Jan 25.
PMID: 27859908RESULTBaryza MJ, Baryza GA. The Vancouver Scar Scale: an administration tool and its interrater reliability. J Burn Care Rehabil. 1995 Sep-Oct;16(5):535-8. doi: 10.1097/00004630-199509000-00013.
PMID: 8537427RESULTJimi S, Kimura M, De Francesco F, Riccio M, Hara S, Ohjimi H. Acceleration Mechanisms of Skin Wound Healing by Autologous Micrograft in Mice. Int J Mol Sci. 2017 Aug 2;18(8):1675. doi: 10.3390/ijms18081675.
PMID: 28767054RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
July 17, 2019
First Posted
July 24, 2019
Study Start
October 1, 2017
Primary Completion
October 1, 2018
Study Completion
June 30, 2019
Last Updated
July 24, 2019
Record last verified: 2019-07